Clinical Trial Update: Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole for gastric ulcers has completed, with an update reporting on comparative efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Lansoprazole (Lansoprazole)
• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED